COVID-19: Can we tackle the root cause of inflammation?
acute respiratory distress syndrome.However, there is good evidence to suggest that drugs that reduce inflammation, such as the steroid dexamethasone, can save the lives of patients already on ventilators and those receiving supplemental oxygen.Now, though, scientists at the University of Málaga in Spain and the University of California, Los Angeles, have proposed a novel way to identify patients at high risk of developing hyperinflammation and prevent it from occurring.They hypothesize that healthcare providers could give an existing drug to such patients early in the infection to address the root cause of the excessive immune response.Their proposal appears in the journal Cytokine & Growth Factor Reviews.Stay informed with live updates on.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|